The treatment of cerebral infarction includes general treatment and special treatment, and the general treatment mainly refers to keeping the airway open, oxygenation, cranial pressure lowering treatment, blood pressure control, blood sugar control and lipid regulating and plaque stabilizing treatment. If the patient has aspiration pneumonia, anti-infective treatment should be given promptly. When a patient has seizures, symptomatic treatment is usually given if the first seizure occurs. If the patient has more than two seizures, antiepileptic drugs are usually applied routinely. Special treatment mainly includes thrombolytic therapy in the hyperacute phase with drugs including alteplase and urokinase, and patients in the acute phase are mainly given neurotrophic as well as antiplatelet aggregation therapy. The main neurotrophic drugs commonly used in clinical practice are edaravone, cytarabine, piracetam and cerebroprotein hydrolysate; the main anti-platelet aggregation drugs are aspirin and clopidogrel. If the patient has cerebral embolism, anticoagulation therapy is routinely applied, and commonly used drugs include heparin and low-molecular heparin. If the patient has severe somatic signs and symptoms, butylphthalide is mainly applied clinically to improve the signs and symptoms of neurological deficits. If the patient has impaired consciousness, brain-awakening treatment should be given to wake up the brain.